Società Peregrine Pharmaceuticals Nasdaq
Azioni
US7136615025
Prodotti farmaceutici
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Mammalian Cell Culture
84,0
%
| 99 | 83,0 % | 125 | 84,0 % | +26,32% |
Process Development
16,0
%
| 20 | 17,0 % | 24 | 16,0 % | +17,40% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 120 | 100,0 % | 149 | 100,0 % | +24,81% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 30/07/20 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 01/08/18 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/99 |
Richard Richieri
COO | Chief Operating Officer | 59 | 09/10/19 |
Richard Hancock
BRD | Director/Board Member | 65 | 27/11/17 |
Oksana Lukash
HRO | Human Resources Officer | - | 16/11/22 |
Michael Alston
PRN | Corporate Officer/Principal | - | 01/01/19 |
Michael Faughnan
PRN | Corporate Officer/Principal | - | - |
Elie Hanania
PRN | Corporate Officer/Principal | - | 04/11/21 |
Corporate Officer/Principal | - | 07/10/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 27/11/17 |
Joseph Carleone
CHM | Chairman | 78 | 27/11/17 |
Catherine Mackey
BRD | Director/Board Member | 68 | 25/07/19 |
Nicholas Green
CEO | Chief Executive Officer | 60 | 30/07/20 |
Esther Alegria
BRD | Director/Board Member | 66 | 28/06/21 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 03/12/20 |
Richard Hancock
BRD | Director/Board Member | 65 | 27/11/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 63 479 794 | 62 799 647 ( 98,93 %) | 0 | 98,93 % |
Coordinate società
Settore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
-2,10% | 89,08 Mrd | |
+2,76% | 40,9 Mrd | |
-12,92% | 32,25 Mrd | |
+54,69% | 25,14 Mrd | |
-16,51% | 15,39 Mrd | |
-8,27% | 11,91 Mrd | |
-42,60% | 11,89 Mrd | |
-12,82% | 11,64 Mrd | |
+7,34% | 9,03 Mrd |